Pine Bridge Investments, L.P. Seagen Inc. Transaction History

Pine Bridge Investments, L.P.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 14, 2023	BUY	$191.51 - $216.16 $374,402 - $422,592	1,955 New	1,955 $414,000
Q3 2021 Nov 09, 2021	SELL	$142.45 - $169.82 $1.73 Million - $2.06 Million	-12,135 Closed	0 $0
Q2 2021 Aug 13, 2021	SELL	$135.08 - $161.1 $2.18 Million - $2.6 Million	-16,160 Reduced 57.11%	12,135 $1.92 Million
Q1 2021 May 14, 2021	BUY	$137.51 - $190.8 $1.47 Million - $2.04 Million	10,667 Added 60.51%	28,295 $3.93 Million
Q4 2020 Feb 16, 2021	BUY	$164.63 - $211.93 $2.9 Million - $3.74 Million	17,628 New	17,628 $3.09 Million

1.26M

23K

55.2K

Ticker SGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 185,664,992
Description
Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment ...

Get notified when there are updates to the investment portfolio of Pine Bridge Investments, L.P., based on Form 13F filings with the SEC.

Stay updated on Pine Bridge Investments, L.P. with notifications on news.